Dr Glen Reid receives grant from the Cancer Council NSW

Dr Glen Reid

Dr Glen Reid

Following on from last year’s breakthrough research into the role of microRNAs in malignant pleural mesothelioma, Dr Glen Reid has been awarded a $346,000 grant from the Cancer Council NSW to further ADRI’s research into microRNA-based replacement therapy.

One of just 16 applications funded this year, the project entitled “Developing a microRNA-based drug as a new treatment option for mesothelioma” will investigate in more detail ways in which targeted delivery of microRNAs can be used to inhibit tumour growth in pre-clinical models.

This work will be carried out together with scientists at the biotech company EnGeneIC, with whom ADRI have been collaborating for over two years.